Business Description
PDS Biotechnology is a Princeton-based clinical-stage company focused on developing new treatments for cancer and infectious diseases. Its most advanced therapy, Versamune HPV, is currently in Phase II trials targeting several HPV-related cancers, including head and neck, cervical, and anal cancers. The company also has a range of earlier-stage programs aimed at conditions such as leukemia, breast cancer, and ovarian cancer, alongside a novel flu vaccine. PDS Biotechnology works with partners including the National Institutes of Health and Merck to advance its research.
